{"id":15852,"date":"2026-02-04T17:51:18","date_gmt":"2026-02-04T16:51:18","guid":{"rendered":"https:\/\/www.maunakeatech.com\/?p=15852"},"modified":"2026-02-04T18:00:19","modified_gmt":"2026-02-04T17:00:19","slug":"mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/","title":{"rendered":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States"},"content":{"rendered":"\n<p class=\"has-text-align-center\"><strong><em>Building on Strong 2025 Momentum with Accelerated Sales Growth in Pancreatic Cysts &amp;<\/em> <em>\u20ac1M Milestone for CellTolerance<sup>\u00ae<\/sup><\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong><em>Appointment of Benoit Chardon as Fractional Chief Commercial Officer to Lead Global<\/em> <em>Scale-Up of CellTolerance<sup>\u00ae<\/sup> Outside the <\/em> <em>United States<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong><em>Leveraging European Endoscopy (ESGE) Recommendation to Support Pancreatic Cyst<\/em> <em>Commercial Expansion<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>Paris and Boston, February 4, 2026 \u2013 5:45 p.m. CET \u2013 Mauna Kea Technologies (Euronext Growth: ALMKT)<\/strong>, inventor of Cellvizio<sup>\u00ae<\/sup>, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance<sup>\u00ae<\/sup> (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.<\/p>\n\n\n\n<p>Following significant U.S. commercial restructuring in early 2025, which delivered sustained sales acceleration throughout the year, Mauna Kea is now sharpening its international strategy outside the United States. The organizational changes aim to capitalize on proven clinical momentum in pancreatic cyst characterization and unlock the high-potential market for CellTolerance in Europe, the Middle East, Australia, and beyond.<\/p>\n\n\n\n<p><br>Benoit Chardon, who has served as Senior Strategic Advisor since 2024 and played a pivotal role in shaping the CellTolerance value proposition, branding, go-to-market strategy, and initial commercial rollout (Europe, Australia, and other regions), is appointed Fractional Chief Commercial Officer dedicated to CellTolerance. With over 20 years of proven leadership in healthcare, weight loss, and medical aesthetics, Benoit Chardon has developed scalable playbooks for revenue development and value creation.<\/p>\n\n\n\n<p>Under his leadership, a dedicated, outsourced commercial and marketing team will drive CellTolerance scaling with the following key priorities for 2026:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Accelerating new account acquisition and lead generation;<\/li>\n\n\n\n<li>Securing strategic partnerships with leading clinics and distributors;<\/li>\n\n\n\n<li>Rolling out standardized, high-quality commercial, clinical, and patient-experience frameworks to ensure consistent execution and sustainable clinic growth.<\/li>\n<\/ul>\n\n\n\n<p><em>\u201cCellTolerance<sup>\u00ae<\/sup> has proven strong clinical relevance and market traction globally, reaching \u20ac1 million in sale in 2025,\u201d<\/em> said <strong>Benoit Chardon<\/strong>. <em>\u201cWe are now entering the execution phase to replicate proven scalable models I have successfully deployed before. Our goal is disciplined, high-quality scaling to make CellTolerance the go-to solution for food intolerance diagnosis in Europe and key international markets, targeting significant growth in the coming years through disciplined expansion and partnerships. With current users already describing CellTolerance as an \u2018essential technology\u2019 for their patients, we see a compelling and immediate opportunity to address a large, underserved market.\u201d<\/em><\/p>\n\n\n\n<p>In addition to CellTolerance, the commercial efforts will prioritize pancreatic cyst characterization outside the U.S., an indication with strong clinical momentum. This leverages landmark achievements including positive CLIMB study results, the recent inclusion of Cellvizio<sup>\u00ae<\/sup> in the European Society of Gastrointestinal Endoscopy (ESGE) technical guidelines, and an ongoing review by the French National Authority for Health (Haute Autorit\u00e9 de Sant\u00e9) that could unlock reimbursement in France.<\/p>\n\n\n\n<p><strong>Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies<\/strong>, commented: <em>\u201c2025 marked a turning point with record U.S. momentum in pancreatic cysts and CellTolerance emerging as a true second pillar. To seize the international opportunity ahead, we are adapting our organization with clear focus and the right expertise. Benoit\u2019s proven track record in scaling high-growth healthcare businesses makes him the right leader to structure and accelerate CellTolerance globally. 2026 will be the year we move from the CellTolerance pilot phase into meaningful, recurring growth alongside building pancreatic cyst momentum outside the U.S.\u201d<\/em><\/p>\n\n\n\n<p class=\"has-text-align-left\"><a href=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2026\/02\/PR_ALMKT_Organisation_February-2026_EN.pdf\">READ THE COMPLETE PRESS RELEASE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Building on Strong 2025 Momentum with Accelerated Sales Growth in Pancreatic Cysts &amp; \u20ac1M Milestone for CellTolerance\u00ae Appointment of Benoit Chardon as Fractional Chief Commercial Officer to Lead Global Scale-Up of CellTolerance\u00ae Outside the United States Leveraging European Endoscopy (ESGE) Recommendation to Support Pancreatic Cyst Commercial Expansion Paris and Boston, February 4, 2026 \u2013 5:45 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":2811,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34],"tags":[],"class_list":["post-15852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-int"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies<\/title>\n<meta name=\"description\" content=\"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T16:51:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-04T17:00:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elizabeth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elizabeth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\"},\"author\":{\"name\":\"Elizabeth\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\"},\"headline\":\"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States\",\"datePublished\":\"2026-02-04T16:51:18+00:00\",\"dateModified\":\"2026-02-04T17:00:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\"},\"wordCount\":571,\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"int\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\",\"url\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\",\"name\":\"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png\",\"datePublished\":\"2026-02-04T16:51:18+00:00\",\"dateModified\":\"2026-02-04T17:00:19+00:00\",\"author\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\"},\"description\":\"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#breadcrumb\"},\"inLanguage\":\"int\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage\",\"url\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png\",\"contentUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.maunakeatech.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.maunakeatech.com\/#website\",\"url\":\"https:\/\/www.maunakeatech.com\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.maunakeatech.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"int\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\",\"name\":\"Elizabeth\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"caption\":\"Elizabeth\"},\"url\":\"https:\/\/www.maunakeatech.com\/int\/author\/elizabeth\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies","description":"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/","og_locale":"en_US","og_type":"article","og_title":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies","og_description":"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.","og_url":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2026-02-04T16:51:18+00:00","article_modified_time":"2026-02-04T17:00:19+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png","type":"image\/png"}],"author":"Elizabeth","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"Written by":"Elizabeth","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/"},"author":{"name":"Elizabeth","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"headline":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States","datePublished":"2026-02-04T16:51:18+00:00","dateModified":"2026-02-04T17:00:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/"},"wordCount":571,"image":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png","articleSection":["News"],"inLanguage":"int"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/","url":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/","name":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png","datePublished":"2026-02-04T16:51:18+00:00","dateModified":"2026-02-04T17:00:19+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"description":"Mauna Kea Technologies announced key organizational changes to drive accelerated growth outside the United States. These moves build directly on the strong 2025 sales performance positioning the Company with two major growth drivers: pancreatic cysts and CellTolerance\u00ae (detection of food intolerances in patients suffering from IBS) scaling rapidly internationally.","breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#breadcrumb"},"inLanguage":"int","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/2a48e7c30eaca6401502fa8f1686279895b0e4e9.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-new-commercial-organization-to-accelerate-growth-outside-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"int"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82","name":"Elizabeth","image":{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","caption":"Elizabeth"},"url":"https:\/\/www.maunakeatech.com\/int\/author\/elizabeth\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/15852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/comments?post=15852"}],"version-history":[{"count":1,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/15852\/revisions"}],"predecessor-version":[{"id":15856,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/15852\/revisions\/15856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media\/2811"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media?parent=15852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/categories?post=15852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/tags?post=15852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}